国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2009年
7期
65-66
,共2页
邓德柱%石炳文%刘兴民%王全胜%练永芬
鄧德柱%石炳文%劉興民%王全勝%練永芬
산덕주%석병문%류흥민%왕전성%련영분
增生性瘢痕%积雪草甙
增生性瘢痕%積雪草甙
증생성반흔%적설초대
Hypertrophic sear%Asiaticoside
目的 研究积雪草甙治疗增生性瘢痕的临床疗效.方法 68例增生性瘢痕患者口服积雪草甙片剂3.6mg/(kg·d),分3次服,同时外用霜剂,每天3次.观察病人的症状和体征变化,给以定量评分以评估其疗效,并观察其毒性及副作用.结果 68例患者中,显效18例(占26.5%),有效45例(占66.2%),无效5例(占7.3%).副作用发生率比较低,未发现明显毒性反应.结论 积雪草甙对瘢痕增生一定的治疗的作用,是有效、安全、易为患者接受的药物.
目的 研究積雪草甙治療增生性瘢痕的臨床療效.方法 68例增生性瘢痕患者口服積雪草甙片劑3.6mg/(kg·d),分3次服,同時外用霜劑,每天3次.觀察病人的癥狀和體徵變化,給以定量評分以評估其療效,併觀察其毒性及副作用.結果 68例患者中,顯效18例(佔26.5%),有效45例(佔66.2%),無效5例(佔7.3%).副作用髮生率比較低,未髮現明顯毒性反應.結論 積雪草甙對瘢痕增生一定的治療的作用,是有效、安全、易為患者接受的藥物.
목적 연구적설초대치료증생성반흔적림상료효.방법 68례증생성반흔환자구복적설초대편제3.6mg/(kg·d),분3차복,동시외용상제,매천3차.관찰병인적증상화체정변화,급이정량평분이평고기료효,병관찰기독성급부작용.결과 68례환자중,현효18례(점26.5%),유효45례(점66.2%),무효5례(점7.3%).부작용발생솔비교저,미발현명현독성반응.결론 적설초대대반흔증생일정적치료적작용,시유효、안전、역위환자접수적약물.
Objective To study the therapeutic effect of asiaticoside on hyperplastie scars, Methods 68cases with hyperplastic scars were randomly divided into two groups. The experiment group was administered tablet asiaticoside orally, and asiaticoside cream was used at the same time. The change of patients' symptoms and signs were observed, also the toxicity and the side effect of asiaticoside were observed. Results The hypertrophy of scars was significantly inhibited by Asiaticoside, and the scars has became softening. 3 cases had skin rash after used the cream, but disappeared when stopped usage. In addition, Asiaticoside had no other toxicities and side effects for children body. Conclusion Asiaticoside is effective and safe in the treatment of hyperplastic scar.